<VariationArchive RecordType="classified" VariationID="2688" VariationName="NC_000007.14:g.(45018761_45019059)_(45095530_45095828)del" VariationType="Deletion" Accession="VCV000002688" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-11-25" DateCreated="2013-04-04" MostRecentSubmission="2023-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17727" VariationID="2688">
      <GeneList>
        <Gene Symbol="CCM2" FullName="CCM2 scaffold protein" GeneID="83605" HGNC_ID="HGNC:21708" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>7p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="44999746" stop="45076470" display_start="44999746" display_stop="45076470" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="45039344" stop="45116068" display_start="45039344" display_stop="45116068" Strand="+" />
          </Location>
          <OMIM>607929</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.14:g.(45018761_45019059)_(45095530_45095828)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p13</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>7p13 deletion (77.6 kb)</Name>
        <Name>77.6-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="NCBI36" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.12" sequenceAccession="NC_000007" sequenceVersion="12" change="g.(45024885_45025183)_(45101654_45101952)del" Assembly="NCBI36">
            <Expression>NC_000007.12:g.(45024885_45025183)_(45101654_45101952)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.(45018761_45019059)_(45095530_45095828)del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.(45018761_45019059)_(45095530_45095828)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415012" DB="dbVar" />
        <XRef ID="nsv513784" DB="dbVar" />
        <XRef Type="Allelic variant" ID="607929.0009" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for OMIM allelic variant 607929.0009 from this description in the paper by et al., (PubMed ): the proximal breakpoint within an AluSx repeat mapping in intron 1 (chr7:45024885–45025183) and the distal breakpoint within an AluSg repeat in the intragenic region (chr7:45101654–45101952).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.14:g.(45018761_45019059)_(45095530_45095828)del AND Cerebral cavernous malformation 2" Accession="RCV000002807" Version="5">
        <ClassifiedConditionList TraitSetID="684">
          <ClassifiedCondition DB="MedGen" ID="C1864041">Cerebral cavernous malformation 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-08-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-08-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2023-06-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17160895</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18060436</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301470</ID>
          <ID Source="BookShelf">NBK1293</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="868" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebral cavernous malformations 2</ElementValue>
                <XRef ID="Cerebral+cavernous+malformations+2/7938" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cerebral cavernous malformation 2</ElementValue>
                <XRef ID="MONDO:0011304" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CCM2</ElementValue>
                <XRef Type="MIM" ID="603284" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cerebral cavernous malformations (CCMs) are vascular malformations in the brain and spinal cord comprising closely clustered, enlarged capillary channels (caverns) with a single layer of endothelium without mature vessel wall elements or normal intervening brain parenchyma. The diameter of CCMs ranges from a few millimeters to several centimeters. CCMs increase or decrease in size and increase in number over time. Hundreds of lesions may be identified, depending on the person's age and the quality and type of brain imaging used. Although CCMs have been reported in infants and children, the majority become evident between the second and fifth decades with findings such as seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage. Up to 50% of individuals with FCCM remain symptom free throughout their lives. Cutaneous vascular lesions are found in 9% of those with familial cerebral cavernous malformations (FCCM; see Diagnosis/testing) and retinal vascular lesions in almost 5%.</Attribute>
                <XRef ID="NBK1293" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18313" />
                <XRef ID="18313" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301470</ID>
                <ID Source="BookShelf">NBK1293</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Cavernoma Alliance UK, 2012">
                <URL>https://www.guideline.gov/summaries/summary/49007</URL>
              </Citation>
              <XRef ID="221061" DB="Orphanet" />
              <XRef ID="C1864041" DB="MedGen" />
              <XRef ID="MONDO:0011304" DB="MONDO" />
              <XRef Type="MIM" ID="603284" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="576293" SubmissionDate="2016-08-04" DateLastUpdated="2016-08-22" DateCreated="2016-08-22">
        <ClinVarSubmissionID localKey="77.6-kb deletion|OMIM:603284" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000297821" DateUpdated="2016-08-22" DateCreated="2016-08-22" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17160895</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18060436</ID>
          </Citation>
          <Citation>
            <URL>http://www.ncbi.nlm.nih.gov/books/NBK1293/</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">77.6-kb deletion</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="603284" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="22965" SubmissionDate="2021-03-10" DateLastUpdated="2023-06-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607929.0009_CEREBRAL CAVERNOUS MALFORMATIONS 2" title="CCM2, 77.6-KB DEL_CEREBRAL CAVERNOUS MALFORMATIONS 2" />
        <ClinVarAccession Accession="SCV000022965" DateUpdated="2023-06-17" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Among a cohort of 63 families with cerebral cavernous malformations (CCM2; 603284), Liquori et al. (2007) identified a heterozygous 77.6-kb deletion in the CCM2 gene in 8 probands (13%). The deletion encompassed exons 2 through 10, with the proximal breakpoint within an AluSx repeat in intron 1 and the distal breakpoint within an AluSg repeat distal to exon 10. Haplotype analysis suggested that this deletion may have occurred independently at least twice in their cohort, although the evidence was not conclusive.</Attribute>
              <Citation>
                <ID Source="PubMed">17160895</ID>
              </Citation>
              <XRef DB="OMIM" ID="603284" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Liquori et al. (2008) reported 6 additional CCM families from the United States with the 77.6-kb CCM2 deletion. Haplotype analysis, which included the previously reported families with this deletion, indicated a founder effect. This deletion was not present in 24 Italian families with CCM, indicating that it is specific to a certain cohort of patients.</Attribute>
              <Citation>
                <ID Source="PubMed">18060436</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCM2" />
          </GeneList>
          <Name>CCM2, 77.6-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">77.6-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607929.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEREBRAL CAVERNOUS MALFORMATIONS 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22965" TraitType="Disease" MappingType="Name" MappingValue="CEREBRAL CAVERNOUS MALFORMATIONS 2" MappingRef="Preferred">
        <MedGen CUI="C1864041" Name="Cerebral cavernous malformation 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="576293" TraitType="Disease" MappingType="XRef" MappingValue="603284" MappingRef="OMIM">
        <MedGen CUI="C1864041" Name="Cerebral cavernous malformation 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

